Anemia is the most common blood disorder in the world, and it is also one of the most frequently missed. It is not a disease in itself but a signal: your blood is not carrying enough oxygen to your tissues, and something upstream is causing that shortfall. A 2025 review in JAMA estimated that iron-deficiency anemia alone affects roughly 1.2 billion people worldwide, including about 10 million people in the United States, while absolute iron deficiency without anemia touches around 14% of American adults.
That distinction matters. Anemia is the late stage of a process that starts silently, often months earlier, with iron stores draining away. This guide walks through what anemia is, how it feels, what causes it, which laboratory markers identify it, and what current evidence says about treating it well.
What is anemia?
Anemia is defined as a hemoglobin concentration below the reference range for your age and sex. Hemoglobin is the iron-containing protein inside red blood cells that binds oxygen in the lungs and releases it in the tissues. When hemoglobin falls, every organ receives slightly less oxygen than it expects, and the body compensates by raising heart rate, increasing breathing rate, and redirecting blood flow toward the brain and heart.
The World Health Organization thresholds most laboratories use are approximately below 13.0 g/dL for men, below 12.0 g/dL for non-pregnant women, and below 11.0 g/dL during pregnancy. These are population cutoffs, not personal ones. A value of 12.2 g/dL may be entirely normal for one woman and represent a meaningful drop for another whose baseline was 14.5 g/dL, which is why trends over time carry more information than a single reading.
Anemia is usually classified by red cell size, measured as mean corpuscular volume. Microcytic anemia, with small cells, points toward iron deficiency or thalassemia. Normocytic anemia, with normal-sized cells, suggests bleeding, chronic disease, kidney disease, or bone marrow failure. Macrocytic anemia, with large cells, points toward vitamin B12 or folate deficiency, alcohol use, or certain medications. If you want to see how these red cell indices fit together, you can read our red blood cell test results guide.
Symptoms and signs of anemia
Anemia announces itself slowly. Because the body adapts, many people feel nothing until hemoglobin has fallen substantially, and they often attribute the early changes to stress, poor sleep, or aging.
Common symptoms
- Persistent fatigue that rest does not resolve
- Shortness of breath during activity that used to feel easy
- Lightheadedness, especially when standing up quickly
- Headaches and difficulty concentrating
- Cold hands and feet
- Rapid or pounding heartbeat
- Pale skin, gums, nail beds, or inner eyelids
Symptoms specific to iron deficiency
Iron deficiency produces a distinctive cluster that can appear before hemoglobin drops at all. The 2025 JAMA review reported restless legs syndrome in 32% to 40% of people with iron deficiency and pica, the craving for non-food substances such as ice, clay, or paper, in 40% to 50%. Brittle or spoon-shaped nails, hair shedding, cracked corners of the mouth, and a sore or smooth tongue are also characteristic. Irritability, low mood, and reduced exercise tolerance are common and frequently misread as purely psychological.
Signs that need urgent attention
Chest pain, fainting, severe breathlessness at rest, black or tarry stools, vomiting blood, or a rapidly worsening pallor all warrant immediate medical assessment. In someone with existing heart disease, anemia can precipitate or worsen heart failure.
Causes and risk factors
Anemia has three basic mechanisms: you are losing red cells, you are not making enough, or you are destroying them too fast. Most real cases involve one dominant mechanism with contributing factors layered on top.
Blood loss
Recurrent blood loss is responsible for the overwhelming majority of iron-deficiency anemia. A 2025 clinical review in American Family Physician put the figure at roughly 94% of cases. In premenopausal women, heavy menstrual bleeding is the leading cause. In men and postmenopausal women, unexplained iron deficiency is treated as gastrointestinal bleeding until proven otherwise, because it may be the first sign of a peptic ulcer, an angiodysplasia, or a colorectal tumor. Anyone in that group should discuss endoscopic evaluation with a clinician, and a fecal occult blood test results guide explains what the initial screening step looks for.
Reduced production
- Iron deficiency from inadequate intake or poor absorption, including celiac disease, atrophic gastritis, bariatric surgery, and chronic use of acid-suppressing medication
- Vitamin B12 or folate deficiency, common in strict vegan diets, pernicious anemia, and long-term metformin use
- Anemia of inflammation, in which chronic infection, autoimmune disease, or cancer raises hepcidin and locks iron away from the bone marrow
- Chronic kidney disease, which reduces erythropoietin production
- Bone marrow disorders such as aplastic anemia, myelodysplastic syndromes, and leukemia
- Hypothyroidism, which lowers red cell production through several routes
Increased destruction
Hemolytic anemias include inherited conditions such as sickle cell disease, thalassemia, hereditary spherocytosis, and glucose-6-phosphate dehydrogenase deficiency, as well as acquired autoimmune hemolysis and drug-induced hemolysis. Mechanical heart valves and severe infections can also shorten red cell survival.
Who is most at risk
Risk concentrates in menstruating women, pregnant women, infants and children under five, older adults, people with inflammatory bowel disease or celiac disease, frequent blood donors, endurance athletes, and people with low socioeconomic status or limited dietary variety.
How is anemia diagnosed?
Diagnosis proceeds in two steps: confirm that anemia exists, then find its cause. Skipping the second step is the most common clinical error.
The first-line blood tests
| Test | What it tells you |
|---|---|
| Complete blood count | Confirms low hemoglobin and hematocrit, and gives red cell size and variability |
| Mean corpuscular volume | Sorts the anemia into microcytic, normocytic, or macrocytic |
| Reticulocyte count | Shows whether the marrow is responding; low counts suggest a production problem |
| Ferritin | The single best marker of iron stores in the absence of inflammation |
| Transferrin saturation | Reflects iron available for red cell production right now |
| C-reactive protein | Detects inflammation that would falsely raise ferritin |
Interpreting ferritin correctly
Ferritin is where most diagnostic confusion happens, because it rises during inflammation regardless of iron status. Current guidance in the 2025 American Family Physician review sets the thresholds this way: in adults without inflammation, ferritin below 45 ng/mL is diagnostic of iron deficiency, and ferritin between 46 and 99 ng/mL combined with transferrin saturation below 20% is also diagnostic. In the presence of inflammation, the cutoff rises to below 100 ng/mL. Older laboratory ranges that treat 15 ng/mL as the lower limit will miss a large number of genuinely iron-deficient people. Our ferritin blood level guide covers this threshold question in more detail, and readers tracking iron transport can also consult our transferrin saturation results guide.
Second-line investigation
Depending on the pattern, clinicians add vitamin B12 and folate, kidney and thyroid function, celiac serology, hemoglobin electrophoresis, direct antiglobulin testing, or a peripheral blood smear. Bone marrow biopsy is reserved for unexplained cases or suspected marrow disease. Anyone with unexplained iron deficiency and no obvious source of bleeding should be evaluated for gastrointestinal loss and for Helicobacter pylori infection, which impairs iron absorption.
Treatment options for anemia
Treatment has two halves that must run in parallel: correct the anemia and fix the cause. Iron tablets given without investigating why iron is low will mask a bleeding lesion.
Oral iron
Oral iron salts remain first-line therapy for uncomplicated iron deficiency. The important shift in recent practice is dosing frequency. Because a single iron dose raises hepcidin for about 24 hours and blunts absorption of the next dose, alternate-day dosing of a single tablet absorbs more total iron than the traditional two or three doses daily, and causes far less nausea and constipation. Taking iron with vitamin C or a source of ascorbic acid improves uptake; taking it with coffee, tea, calcium, or antacids reduces it substantially. Hemoglobin typically begins rising within two to four weeks, but replenishing stores takes three to six months of continued therapy.
Intravenous iron
Intravenous iron has moved from last resort to a routine option. It is preferred when oral iron is not tolerated or not absorbed, in inflammatory bowel disease, after bariatric surgery, in chronic kidney disease, in the second and third trimesters of pregnancy, in heart failure with iron deficiency, and when rapid correction is needed. Modern formulations such as ferric carboxymaltose and ferric derisomaltose deliver a full replacement dose in one or two visits. Serious hypersensitivity reactions are rare with current preparations, and transient hypophosphatemia is the main monitoring concern with some formulations.
Other targeted treatments
- Vitamin B12 by injection or high-dose oral supplementation for B12 deficiency, with lifelong therapy in pernicious anemia
- Folic acid supplementation for folate deficiency
- Erythropoiesis-stimulating agents for anemia of chronic kidney disease, used cautiously alongside adequate iron
- Treating the underlying inflammation, infection, or malignancy in anemia of inflammation
- Immunosuppression for autoimmune hemolytic anemia
- Disease-modifying therapy, including hydroxyurea and newer agents, in sickle cell disease
- Red cell transfusion, reserved for severe or symptomatic anemia and guided by restrictive thresholds rather than a fixed hemoglobin number
Prevention and lifestyle management
Diet cannot fix an established deficiency quickly, but it protects against recurrence and supports treatment.
Getting iron from food
Heme iron from red meat, poultry, and fish is absorbed at roughly 15% to 35%. Non-heme iron from lentils, beans, tofu, spinach, fortified cereals, pumpkin seeds, and dried apricots is absorbed at around 2% to 20%, and that figure moves substantially depending on what else is on the plate. Pairing plant sources with peppers, citrus, tomatoes, or broccoli raises absorption; pairing them with tea, coffee, or a calcium supplement lowers it. Cooking in cast iron adds a modest amount.
Supporting nutrients
Vitamin B12 comes from animal foods and fortified products, so anyone eating a vegan diet needs a reliable supplement. Folate comes from leafy greens, legumes, and fortified grains. Copper and vitamin A both play supporting roles in iron metabolism, and severe deficiency of either can produce anemia that does not respond to iron alone. Readers monitoring B12 can consult our vitamin B12 level guide.
Habits that help
Treat heavy menstrual bleeding rather than accepting it. Space iron supplements away from acid-blocking medication. Screen for celiac disease if iron deficiency keeps recurring despite adequate intake. Maintain a sensible gap between blood donations. Endurance athletes should have ferritin checked periodically, since foot-strike hemolysis and inflammation both drain iron stores.
Living with anemia: prognosis and outlook
For the great majority of people, the outlook is excellent. Iron-deficiency anemia from a correctable cause resolves completely, and the fatigue, breathlessness, and cognitive fog reverse as hemoglobin and iron stores rebuild. Many people report that their pre-treatment baseline was not actually normal, and only recognize the difference in retrospect.
Chronic anemias behave differently. Anemia of kidney disease, inherited hemolytic anemias, and marrow disorders require ongoing management rather than a cure, and the goal shifts to maintaining a functional hemoglobin with the fewest complications. Untreated anemia carries real costs: reduced work capacity, impaired cognitive development in children, higher risk of adverse pregnancy outcomes, longer hospital stays, and worse outcomes in heart failure.
Follow-up matters. Recheck hemoglobin and ferritin after two to three months of therapy, then again once treatment ends, because relapse is common when the underlying cause remains unaddressed.
Latest scientific advances
Research over the past three years has reshaped several parts of routine practice, and the evidence below comes from PubMed-indexed sources.
Higher diagnostic thresholds for iron deficiency
The 2025 JAMA review by Auerbach and colleagues, together with the 2025 American Family Physician update, formalized the shift away from the old ferritin cutoff of 15 ng/mL toward thresholds of 45 ng/mL without inflammation and 100 ng/mL with inflammation. This single change reclassifies a large number of previously reassured patients as genuinely iron deficient, and it explains why so many people with borderline ferritin and classic symptoms improve dramatically on treatment.
Iron deficiency without anemia is now treated in its own right
The same literature emphasizes that fatigue, restless legs, pica, and reduced exercise capacity occur at the stage of depleted stores, before hemoglobin falls. Treating this earlier stage, rather than waiting for the hemoglobin threshold to be crossed, is increasingly standard.
Alternate-day oral dosing
Hepcidin physiology now underpins dosing recommendations. Because each dose suppresses absorption of the next for about a day, giving a single daily-equivalent dose every other day increases fractional absorption and cumulative iron uptake while reducing gastrointestinal side effects. This has become a mainstream recommendation rather than an experimental approach.
Broader use of intravenous iron
Modern intravenous formulations have expanded indications considerably, with the strongest recent momentum in heart failure with reduced ejection fraction, inflammatory bowel disease, chronic kidney disease, and pregnancy, where oral iron is often poorly absorbed or poorly tolerated. Trials in heart failure have consistently shown improvements in symptoms and functional capacity when iron deficiency is corrected intravenously.
Hepcidin as a research and diagnostic target
Hepcidin measurement is moving toward clinical use as a way to distinguish true iron deficiency from anemia of inflammation, and hepcidin-modulating agents are under active investigation for both iron-restricted anemias and iron-overload disorders.
Myths and facts about anemia
| Myth | Fact |
|---|---|
| Anemia always means iron deficiency | Iron deficiency is the most common cause, but B12 deficiency, kidney disease, inflammation, hemolysis, and marrow disorders all produce anemia |
| Eating spinach will cure it | Non-heme iron from spinach is poorly absorbed and cannot replace therapeutic dosing in an established deficiency |
| A normal hemoglobin rules out iron deficiency | Iron stores can be exhausted while hemoglobin remains within range; ferritin is the marker that detects this |
| More iron tablets per day means faster recovery | Hepcidin blocks absorption after each dose, so more frequent dosing mainly increases side effects |
| Anemia is a normal part of aging | Anemia in older adults always warrants investigation and is associated with worse outcomes when ignored |
| Iron supplements are harmless | Unnecessary iron is genuinely harmful in hemochromatosis and other iron-loading conditions |
Frequently asked questions
What causes iron-deficiency anemia most often?
Chronic blood loss accounts for roughly 94% of cases. In premenopausal women that usually means heavy menstrual bleeding; in men and postmenopausal women it means gastrointestinal bleeding until proven otherwise.
What are the earliest symptoms of anemia?
Unexplained fatigue, breathlessness on mild exertion, poor concentration, cold extremities, and restless legs at night. Pica and hair shedding are strong pointers toward iron deficiency specifically.
How long does it take to recover from anemia?
Hemoglobin usually starts rising within two to four weeks of effective treatment and normalizes within six to eight weeks. Rebuilding iron stores takes another three to six months, which is why stopping treatment as soon as hemoglobin normalizes leads to relapse.
What is the fastest way to correct anemia?
Intravenous iron corrects iron-deficiency anemia faster than tablets and is the preferred route when speed matters, when oral iron is not absorbed, or when it is not tolerated. Transfusion is faster still but is reserved for severe or symptomatic cases.
Can anemia cause heart problems?
Yes. Sustained anemia forces the heart to work harder and can worsen existing heart failure or angina. Correcting iron deficiency in heart failure improves symptoms and functional capacity.
Does anemia affect the eyes?
Pallor of the inner eyelid is a recognized clinical sign, and severe anemia can cause blurred vision or visual disturbance through reduced oxygen delivery. Eyelid appearance alone is not a reliable self-test, since it misses mild cases.
Can children have anemia?
Yes, and children under five are among the highest-risk groups. Iron deficiency in early childhood can affect cognitive and motor development, which is why routine screening is recommended in many pediatric protocols.
Is anemia contagious?
No. Anemia is not transmissible. Some infections that cause anemia are contagious, but the anemia itself is not.
Glossary of key terms
- Hemoglobin: the iron-containing protein in red blood cells that carries oxygen
- Hematocrit: the percentage of blood volume occupied by red cells
- Ferritin: the storage form of iron and the primary marker of iron reserves
- Transferrin saturation: the proportion of iron-transport protein currently carrying iron
- Mean corpuscular volume: the average size of red blood cells
- Reticulocytes: newly released immature red cells, a measure of marrow response
- Hepcidin: the hormone that regulates iron absorption and release
- Hemolysis: premature destruction of red blood cells
- Erythropoietin: the kidney hormone that stimulates red cell production
Sources
- Auerbach M, DeLoughery TG, Tirnauer JS — Iron Deficiency in Adults: A Review — JAMA, 2025 — doi.org/10.1001/jama.2025.0452
- Latimer K, Baci G, Layne M — Iron Deficiency Anemia: Evaluation and Management — American Family Physician, 2025;112(5):538-545 — pubmed.ncbi.nlm.nih.gov
- National Heart, Lung, and Blood Institute — Anemia — NIH Health Topics, reviewed 2024 — nhlbi.nih.gov
- MedlinePlus, National Library of Medicine — Anemia — MedlinePlus Health Topic, reviewed 2025 — medlineplus.gov
- Mayo Clinic Staff — Iron Deficiency Anemia — Mayo Clinic Diseases & Conditions, 2025 — mayoclinic.org
- Cleveland Clinic — Anemia — Cleveland Clinic Health Library, 2024 — my.clevelandclinic.org
Further reading
- Check the marker that reveals depleted iron stores before hemoglobin falls by reading our ferritin blood level guide.
- See how red cell size and count are reported on a complete blood count in our red blood cell test results guide.
- Understand how much iron is actually available for red cell production by consulting our transferrin saturation results guide.
- Rule out the most common cause of macrocytic anemia by reviewing our vitamin B12 level guide.
- Investigate hidden gastrointestinal blood loss with our fecal occult blood test results guide.
- Explore how a stomach infection quietly blocks iron absorption in our Helicobacter pylori antigen test guide.
Understand your lab results with BloodSense
Anemia is rarely obvious from one number. It shows up in the relationship between hemoglobin, red cell size, ferritin, transferrin saturation, and inflammatory markers, and that pattern is what points to the cause. BloodSense reads your complete blood count and iron panel together, explains what each value means in plain language, and highlights the combinations worth discussing with your doctor.
Understand your lab results with BloodSense
This article is for informational purposes and does not replace medical advice. Discuss any abnormal result and any change to treatment with a qualified healthcare professional.
